相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
S. Bellone et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody
Christine E. Richter et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Markus Munz et al.
CANCER RESEARCH (2009)
Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer Implications for Epithelial Cell Adhesion Molecule-Specific Immunotherapy
Stefania Bellone et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody
Shoshana Morecki et al.
EXPERIMENTAL HEMATOLOGY (2008)
Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM
Markus Munz et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody:: A phase I/II study
Alexander Burges et al.
CLINICAL CANCER RESEARCH (2007)
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy
Eliana Bignotti et al.
GYNECOLOGIC ONCOLOGY (2006)
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
Gilbert Spizzo et al.
GYNECOLOGIC ONCOLOGY (2006)
Potent inhibition of local and disseminated tumor growth in immunocompetent mouse models by a bispecific antibody construct specific for Murine CD3
B Schlereth et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors
K Brischwein et al.
MOLECULAR IMMUNOLOGY (2006)
Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes
S Morecki et al.
BLOOD (2006)
Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct
B Schlereth et al.
CANCER RESEARCH (2005)
Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
AD Santin et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
EpCAM - A new therapeutic target for an old cancer antigen
A Armstrong et al.
CANCER BIOLOGY & THERAPY (2003)
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
RE Bristow et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
CD8+ tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis
S Radoja et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
